TELA Bio, Inc. TELA
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.09% | 13.48% | 15.84% | 12.24% | 16.34% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.09% | 13.48% | 15.84% | 12.24% | 16.34% |
| Cost of Revenue | 4.51% | 12.57% | 13.92% | 16.33% | 21.59% |
| Gross Profit | 6.83% | 13.91% | 16.76% | 10.40% | 14.00% |
| SG&A Expenses | -0.60% | 0.85% | -0.62% | -5.89% | -2.42% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.18% | 3.28% | 2.73% | -1.53% | 1.27% |
| Operating Income | 8.75% | 14.97% | 19.04% | 22.27% | 19.73% |
| Income Before Tax | -0.22% | 9.04% | -1.62% | 5.94% | 3.04% |
| Income Tax Expenses | 549.15% | 358.70% | 259.72% | -- | -- |
| Earnings from Continuing Operations | -1.01% | 8.30% | -2.62% | 6.08% | 3.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.01% | 8.30% | -2.62% | 6.08% | 3.18% |
| EBIT | 8.75% | 14.97% | 19.04% | 22.27% | 19.73% |
| EBITDA | 8.83% | 15.28% | 19.51% | 23.04% | 20.55% |
| EPS Basic | 30.64% | 43.42% | 40.20% | 47.45% | 34.86% |
| Normalized Basic EPS | 32.74% | 45.06% | 52.43% | 55.48% | 44.70% |
| EPS Diluted | 30.64% | 43.42% | 40.20% | 47.45% | 34.86% |
| Normalized Diluted EPS | 32.74% | 45.06% | 52.43% | 55.48% | 44.70% |
| Average Basic Shares Outstanding | 36.27% | 48.27% | 64.65% | 78.93% | 58.23% |
| Average Diluted Shares Outstanding | 36.27% | 48.27% | 64.65% | 78.93% | 58.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |